Abstract
Alternatively spliced natural soluble isoforms of immunomodulatory receptors [cytotoxic T lymphocyte antigen-4 (CTLA-4), 4-1BB, and programmed death-1 (PD-1)/PD-L1] have been overlooked in favor of their cell-surface-bound counterparts that have generated blockbuster antibodies for the treatment of cancer. We propose that the soluble variants of these receptors contribute to immune regulation and offer potential as targets for immunotherapy.
Original language | English |
---|---|
Pages (from-to) | 771-774 |
Number of pages | 4 |
Journal | Trends in Immunology |
Volume | 39 |
Issue number | 10 |
Early online date | 5 Sept 2018 |
DOIs | |
Publication status | Published - Oct 2018 |